Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro-Reference-Cited by-同舟云学术

Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro

Published:2003-05 Issue:3 Volume:21 Page:197-205
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Freund C.T.F.,Tong X.-W.,Rowley D.,Engehausen D.,Frolov A.,Kieback D.G.,Lerner Seth P.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference60 articles.

1. Intravesical therapy for superficial bladder cancer;Malkowicz;Semin Urol Oncol,2000

2. New approaches to treatment of metastatic bladder cancer;Edelman;Curr Oncol Rep,2000

3. Chemotherapy of bladder carcinoma. Current status and trends;Block;Urologe A,1994

4. Toxicity and results of MVAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced urothelial carcinoma;Witjes;Eur Urol,1997

5. Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir;Tong;Anticancer Res,1996

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro;Tumor Biology;2014-08-02

2. Bladder Cancer: Innovative Approaches Beyond the Diagnosis;Current Medicinal Chemistry;2014-05-31

3. Potent Antitumor Activity of the Combination of HSV-TK and Endostatin by Adeno-associated Virus Vector for Bladder Cancer In Vivo;Clinical Laboratory;2013

4. Suppression of Bladder Cancer Growth by Adeno-associated Virus Vector-mediated Combination of HSV-TK and Endostatin in Vitro;Clinical Laboratory;2013

5. The adeno-associated virus-mediated HSV-TK/GCV suicide system: a potential strategy for the treatment of bladder carcinoma;Medical Oncology;2011-10-20